BioCardia, Inc.
Autologous mononuclear cell therapy (CardiAMP) for ischemic heart failure treatment
- Sector
- Biotech
- Headquarters
- SAN CARLOS, CA
- Latest Form D
- $4M, Jan 2019
- Total capital
- $49.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $49.1M
- 4 Form D · last Jan 2019
- 94 months since last filing
- Federal contracts
- $15K
- 7 awards · Veterans Affairs
- Rank in Biotech#375 of 4373
- Granted patents
- 22
- 18 pending · first 2015
- Rank in peer group#81 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$4M
- Private capital raisedForm D · SEC · 3rd filing$35.9M
- Federal contractVeterans Affairs · Steerable Introducers$5K
- Federal contractVeterans Affairs · Catheter$5K
- Federal contractVeterans Affairs · Purchase Of Medical Equipment$575
- Federal contractVeterans Affairs · Introducer Morph Accesspro$475
- Private capital raisedForm D · SEC · 2nd filing$6.2M
- Private capital raisedForm D · SEC · 1st filing$3M
Show 3 earlier federal awards
- Federal contractVeterans Affairs · Catheter Guide, Morph 8FR 64CM$980
- Federal contractVeterans Affairs · Universal Deflectable Guide Catheter, 124X110CM$1K
- Federal contractVeterans Affairs · Universal Deflectable Guide Catheter, 8 Fr Outsid$1K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
20months
from BioCardia, Inc.’s first federal award to its first private round.
- First federal award · Feb 2008
- Veterans Affairs · $1K
- First Form D · Oct 2009
- $3M · 1st Form D
- Awards before first raise
- 3 awards
An association in public records, not a cause or a prediction.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#81 · top 6%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- PETER ALTMANResearcherExecutive Officer, Director, PromoterLinked by 3 patents
- Allan R. TesslerDirectorNamed in SEC Form D filings
- DAVID L. MCCLUNGExecutive OfficerNamed in SEC Form D filings
- ERIC T. DUCKERSExecutive OfficerNamed in SEC Form D filings
- Fernando L. FernandezDirectorNamed in SEC Form D filings
- Jay M. MoyesDirectorNamed in SEC Form D filings
Show all 13 people
- PHIL M. PESTAExecutive OfficerNamed in SEC Form D filings
- RICHARD T. ALLENExecutive OfficerNamed in SEC Form D filings
- Richard L. KrasnoDirectorNamed in SEC Form D filings
- Richard C. PfennigerDirectorNamed in SEC Form D filings
- RICHARD C. PFENNIGER, JRDirectorNamed in SEC Form D filings
- SIMON H. STERTZERDirectorNamed in SEC Form D filings
- THOMAS C. QUERTERMOUSDirectorNamed in SEC Form D filings
What it has protected
USPTO · 22 granted of 40- PendingRadial And Trans-endocardial Delivery CatheterUSPTOApplication 19191884
- GrantedRadial And Trans-endocardial Delivery CatheterUSPTOUS 12,311,127
- PendingMethod of Accessing A Vascular Site With A Multi-Directional Steerable CatheterUSPTOApplication 18774349
Show all 40 patent records
- Radial And Trans-endocardial Delivery CatheterApr 30, 2026 · Application 19191884Pending
- Radial And Trans-endocardial Delivery CatheterMay 27, 2025 · US 12,311,127Granted
- Method of Accessing A Vascular Site With A Multi-Directional Steerable CatheterMar 13, 2025 · Application 18774349Pending
- Method of Accessing the Left Atrium with a Multi-Directional Steerable CatheterJul 16, 2024 · US 12,036,371Granted
- Radial And Trans-endocardial Delivery CatheterMay 21, 2024 · US 11,986,611Granted
- Bone Marrow Derived NEUROKININ-1 Receptor Positive (NK1R+) Mesenchymal Stem Cells For Therapeutic ApplicationsMar 14, 2024 · Application 18190783Pending
- Methods Of Measuring Potential For Therapeutic Potency And Defining Dosages For Autologous Cell TherapiesNov 28, 2023 · US 11,828,757Granted
- Fetal Stromal Cell Derived Exosomes For Tissue RepairNov 9, 2023 · Application 18343698Pending
- Bone Marrow Derived NEUROKININ-1 Receptor Positive (NK1R+) Mesenchymal Stem Cells For Therapeutic ApplicationsMay 9, 2023 · US 11,642,377Granted
- Multi-Directional Steerable CatheterApr 4, 2023 · US 11,617,859Granted
- Target Site Selection, Entry And Update With Automatic Remote Image AnnotationJun 14, 2022 · US 11,357,463Granted
- Target Site Selection, Entry And Update With Automatic Remote Image AnnotationOct 14, 2021 · Application 17357649Pending
- Multi-Directional Steerable CatheterOct 12, 2021 · US 11,141,568Granted
- Devices and Methods for Accessing the Vasculature of a PatientDec 29, 2020 · US 10,874,831Granted
- Radial And Trans-endocardial Delivery CatheterSep 22, 2020 · US 10,780,248Granted
- Drug Delivery Catheters That Attach To Tissue And Methods For Their UseApr 28, 2020 · US 10,632,281Granted
- Methods Of Measuring Potential For Therapeutic Potency And Defining Dosages For Autologous Cell TherapiesDec 31, 2019 · US 10,520,505Granted
- Radial And Trans-endocardial Delivery CatheterSep 11, 2018 · US 10,071,226Granted
- Method Of Preparing Autologous Cells And Methods Of Use For TherapyJul 31, 2018 · US 10,035,982Granted
- Methods Of Measuring Potential For Therapeutic Potency And Defining Dosages For Autologous Cell TherapiesApr 17, 2018 · US 9,945,854Granted
- Steerable Endoluminal Devices And MethodsMar 29, 2018 · Application 15723646Pending
- Treatment For Chronic Myocardial InfarctSep 21, 2017 · Application 15341471Pending
- Method Of Preparing Autologous Cells And Methods Of Use For TherapySep 5, 2017 · US 9,752,123Granted
- Multi-Directional Steerable CatheterApr 20, 2017 · Application 14887203Pending
- Treatment For Chronic Myocardial InfarctDec 13, 2016 · US 9,517,199Granted
- Treatment for Chronic Myocardial InfarctNov 29, 2016 · US 9,504,642Granted
- Devices and Methods for Accessing the Vasculature of a PatientNov 5, 2015 · Application 14798181Pending
- Method Of Accessing A Contralateral Femoral Artery Of A PatientJul 14, 2015 · US 9,078,994Granted
- Method Of Accessing A Renal Artery Of A PatientMay 5, 2015 · US 9,022,977Granted
- Methods Of Measuring Potential For Therapeutic Potency And Defining Dosages For Autologous Cell TherapiesApr 30, 2015 · Application 14526222Pending
- Method of Implanting a PFO Occluder in a PatientApr 28, 2015 · US 9,017,284Granted
- Method of Accessing a Carotid Artery of a PatientApr 21, 2015 · US 9,011,373Granted
- Implant Delivery Catheter System And Methods For Its UseJan 9, 2014 · Application 14023015Pending
- Method of Treating the HeartJul 18, 2013 · Application 13785886Pending
- Drug Delivery Catheters That Attach To Tissue And Methods For Their UseApplication PCTUS2001048702Pending
- Fetal Stromal Cell Derived Exosomes For Tissue RepairApplication PCTUS2021065586Pending
- Cardiac Stromal Cell Derived Exosomes For Ischemic Heart RepairApplication 63133599Pending
- Methods Of Measuring Potential For Therapeutic Potency And Defining Dosages For Autologous Cell TherapiesApplication 16692862Pending
- Bone Marrow Derived NEUROKININ-1 Receptor Positive (NK1R+) Precursor Cells For Therapeutic ApplicationsApplication PCTUS2019053293Pending
- Bone Marrow Derived NEUROKININ-1 Receptor Positive (NK1R+) Precursor Cells For Therapeutic ApplicationsApplication 62737627Pending
Related companies, and why
- Circulomics Inc.Similar federal contract value in Biotech · $19K in contracts
- ORPHAGEN PHARMACEUTICALS, INC.Similar federal contract value in Biotech · $15K in contracts
- CHEMBIND LLCSimilar federal contract value in Biotech · $15K in contracts
- Guardant HealthSimilar federal contract value in Biotech · $14K in contracts
- PK BIOSCIENCES CORPORATIONSimilar federal contract value in Biotech · $14K in contracts
- Cellular Engineering Technologies, Inc.Similar federal contract value in Biotech · $14K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .